본문

  1. Home
1000 Results:PP:ELSEVIER B V 0.299 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
161
Fighting osteoporosis on two fronts
Fighting osteoporosis on two fronts
Burckhardt, P., | Elsevier Inc | 2006 ,
162
Sex hormone deprivation and bone merabolism in cancer patients
Sex hormone deprivation and bone merabolism in cancer patients
Maria yavropoulou, | Elsevier Inc | 2011 ,
163
Late-phase clinical date to support the clinical relecance of RANKL inhibition
Late-phase clinical date to support the clinical relecance of RANKL inhibition
Silcano Adami, | Elsevier Inc | 2011 ,
164
Early clinical data to support the clinical relevance of RANKL inhibition
Early clinical data to support the clinical relevance of RANKL inhibition
Adolfo Diez- Rerez, | Elsevier Inc | 2011 ,
165
Effect of RANKL inhibition on bone mass,structure, and strength in animal models
Effect of RANKL inhibition on bone mass,structure, and strength in animal models
Serege Ferrari, | Elsevier Inc | 2011 ,
166
The RANK/RANKL/OPG system as a primary regulatory pathway for bone resorption
The RANK/RANKL/OPG system as a primary regulatory pathway for bone resorption
Hofbauer L.C., | Elsevier Inc | 2011 ,
167
Unmet medical need in the management of postmenopausal osteoporosis
Unmet medical need in the management of postmenopausal osteoporosis
Roux C., | Elsevier Inc | 2011 ,
168
Where do we stand on vitamin D?
Where do we stand on vitamin D?
Bischoff-Ferrari, H. A., | Elsevier Inc | 2007 ,
169
HSA: Beyond BMD with DXA
HSA: Beyond BMD with DXA
Lou Bonnick, S., | Elsevier Inc | 2007 ,
170
Is Cortical Bone Hip? What determines Cortical Bone Properties?
Is Cortical Bone Hip? What determines Cortical Bone Properties?
Epstein, S., | Elsevier Inc | 2007 ,
처음이전12131415161718192021이후마지막